CAV1 and osteosarcoma: Nonetheless, our results confirmed that miR-629-5p stimulates the malignant phenotype of osteosarcoma cell lines by directly downregulating CAV1. In addition, our findings suggested that the miR-629-5p-CAV1 interactome represents a potential new target for osteosarcoma treatment.